International liquid biopsy standardization alliance white paper

Area of Science:

• Biomedical Science
• Oncology
• Genetics

Background:

• Precision medicine aims to tailor healthcare using genetic insights.
• Liquid biopsies are crucial for personalized medicine, offering a safer alternative to traditional tissue sampling.

Purpose of the Study:

• To provide an overview of programs within the International Liquid Biopsy Standardization Alliance (ILSA).
• To highlight the objectives, progress, and resources developed by ILSA-affiliated liquid biopsy and standardization initiatives.
• To describe the collaborative efforts and synergies among ILSA members.

Main Methods:

• Review of independent liquid biopsy and standardization programs.
• Analysis of objectives, progress, and developed tools and resources.
• Description of inter-programmatic synergy and unique contributions.

Main Results:

• ILSA unites diverse organizations focused on standardizing liquid biopsy.
• Multiple programs are developing tools and resources to advance liquid biopsy applications.
• Synergies exist within ILSA, fostering collaborative progress in the field.

Conclusions:

• Standardization of liquid biopsy is essential for the advancement of precision medicine.
• ILSA plays a key role in coordinating global efforts for liquid biopsy implementation in oncology.
• Collaborative initiatives are vital for realizing the full potential of liquid biopsies in clinical decision-making and regulatory processes.